← Back to results

Mol Ther · 2019

CRISPR-Pass: Gene Rescue of Nonsense Mutations Using Adenine Base Editors.

Molecular therapy : the journal of the American Society of Gene Therapy, 27(8): 1364-1371 PMID 31164261 DOI 10.1016/j.ymthe.2019.05.013

Open in PubMed ↗ Open via DOI ↗

Abstract

A nonsense mutation is a substitutive mutation in a DNA sequence that causes a premature termination during translation and produces stalled proteins, resulting in dysfunction of a gene. Although it usually induces severe genetic disorders, there are no definite methods for inducing read through of premature termination codons (PTCs). Here, we present a targeted tool for bypassing PTCs, named CRISPR-pass, that uses CRISPR-mediated adenine base editors. CRISPR-pass, which should be applicable to 95.5% of clinically significant nonsense mutations in the ClinVar database, rescues protein synthesis in patient-derived fibroblasts, suggesting potential clinical utility.

Cite